International law firm Bird & Bird advised Stereotaxis, a pioneering American company in surgical robotics for endovascular procedures, in connection with the signing of a definitive agreement for the acquisition of Robocath, a French company based in Rouen specialising in the development of robotic solutions dedicated to the treatment of cardiovascular and neurovascular diseases. This acquisition strengthens Stereotaxis’ positioning as a leadin…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.